Magnetic Field Promotes Migration of Schwann Cells with Chondroitinase ABC (ChABC)-Loaded Superparamagnetic Nanoparticles Across Astrocyte Boundary in vitro
Received 15 August 2019
Accepted for publication 17 December 2019
Published 20 January 2020 Volume 2020:15 Pages 315—332
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Mian Wang
Jianbo Gao, 1 Bing Xia, 1 Shengyou Li, 1 Liangliang Huang, 2 Teng Ma, 1 Xiaowei Shi, 1 Kai Luo, 3 Yujie Yang, 1 Laihe Zhao, 1 Hao Zhang, 4 Beier Luo, 5 Jinghui Huang 1
1Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China; 2Department of Orthopaedics, The General Hospital of Central Theater Command of People’s Liberation Army, Wuhan, People’s Republic of China; 3Department of Orthopaedics, The 985th Hospital of the PLA Joint Logistics Support Force, Taiyuan, People’s Republic of China; 4Department of Spinal Surgery, People’s Hospital of Longhua District, Shenzhen, People’s Republic of China; 5Department of Orthopaedics, Changhai Hospital, Second Military Medical University, Shanghai, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Beier Luo
Department of Orthopaedics, Changhai Hospital, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, People’s Republic of China
Email [email protected]
Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, 169 Changle West Road, Xi’an, Shaanxi 710032, People’s Republic of China
Email [email protected]
Purpose: The clinical outcome of spinal cord injury is usually poor due to the lack of axonal regeneration and glia scar formation. As one of the most classical supporting cells in neural regeneration, Schwann cells (SCs) provide bioactive substrates for axonal migration and release molecules that regulate axonal growth. However, the effect of SC transplantation is limited by their poor migration capacity in the astrocyte-rich central nervous system.
Methods: In this study, we first magnetofected SCs with chondroitinase ABC-polyethylenimine functionalized superparamagnetic iron oxide nanoparticles (ChABC/PEI-SPIONs) to induce overexpression of ChABC for the removal of chondroitin sulfate proteoglycans. These are inhibitory factors and forming a dense scar that acts as a barrier to the regenerating axons. In vitro, we observed the migration of SCs in the region of astrocytes after the application of a stable external magnetic field.
Results: We found that magnetofection with ChABC/PEI-SPIONs significantly up-regulated the expression of ChABC in SCs. Under the driven effect of the directional magnetic field (MF), the migration of magnetofected SCs was enhanced in the direction of the magnetic force. The number of SCs with ChABC/PEI-SPIONs migrated and the distance of migration into the astrocyte region was significantly increased. The number of SCs with ChABC/PEI-SPIONs that migrated into the astrocyte region was 11.6- and 4.6-fold higher than those observed for the intact control and non-MF groups, respectively. Furthermore, it was found that SCs with ChABC/PEI-SPIONs were in close contact with astrocytes and no longer formed boundaries in the presence of MF.
Conclusion: The mobility of the SCs with ChABC/PEI-SPIONs was enhanced along the axis of MF, holding the potential to promote nerve regeneration by providing a bioactive microenvironment and relieving glial obstruction to axonal regeneration in the treatment of spinal cord injury.
Keywords: Schwann cells, astrocytes, magnetic field, superparamagnetic iron oxide nanoparticles, spinal cord injury, cell orientation
The repair of spinal cord injury has traditionally been a challenge in clinics.1,2 In contrast to the intrinsic regenerative properties of axons in the peripheral nervous system (PNS), axons in the central nervous system (CNS) exhibit poor regeneration. The regenerative properties of PNS neurons are partially attributed to extrinsic factors that allow and promote axonal regeneration in the PNS. Schwann cells (SCs), the PNS myelinating glia, perform major functions in creating a favorable environment for axonal growth, stimulating axon outgrowth after injury and rebuilding the myelin sheath of regenerated axons.3–9 Therefore, transplantation of SCs has always been considered a feasible method for the repair of nerve injury and functional reconstruction.10–13 However, the poor migration of SCs in the astrocyte-rich CNS significantly limits their application in the repair of damaged nerves in the CNS.14–16 In addition, astrocytes form a scar barrier to restrict the migration of SCs and do not mix with them. This significantly compromises the ability of SCs to guide regenerating axons into the caudal spinal cord and weakens their ability to mediate remyelination.
To solve this problem, SCs were genetically modified to enhance their ability to break through the scar formed by astrocytes.17 In previous studies, the chondroitinase ABC (ChABC) gene was genetically introduced into SCs to degrade chondroitin sulfate proteoglycans (CSPGs) by cleaving glycosaminoglycan chains,18–20 which were responsible for most of the inhibitory effect.19,21 However, the direct expression of prokaryotic proteins in mammalian cells is problematic since the newly synthesized chondroitin peptide is secreted through eukaryotic cells. Therefore, the chondroitin enzyme genes were modified to enable the transfected cells to effectively secrete the active chondroitin enzyme,20,22 and the full sequence was provided in Supplementary Data. Related research has shown that the sustained expression of modified ChABC by SCs enhanced their ability to traverse the scar formed by astrocytes.23,24 Nevertheless, SCs with ChABC did not migrate along the cephalocaudal direction, which significantly limits their effect on nerve repair after central nerve injury.
Based on the combination of molecular biology and nanotechnology, biomaterials with nanoscale features can induce cell migration, adhesion, proliferation, and differentiation.25 Superparamagnetic ferric oxide nanoparticles (SPIONs) are considered a highly efficient gene transfection vector26,27 and can promote cell migration to the desired direction under the action of MF. In addition, the SPIONs have been certified as a safe magnetic resonance imaging contrast agent by the Food and Drug Administration, which holds many advantages over other gene vectors, such as protection of genes from digestion, low immunogenicity, etc. Following the entry of the target gene binding with SPIONs cells, SPIONs can protect the gene from being degraded by nuclease. Under the action of external MF, the SPIONs/DNA complex rapidly precipitates and contacts with cells, which accelerates the transfection time, and increases the transfection efficiency and DNA endocytosis.28 Moreover, polyethyleneimine (PEI) is coated on the surface of SPIONs to produce a cationic surface, which is more favorable for the cell internalization of the carrier. Particularly, an external magnetic field (MF) could produce force along the MF by acting on the internalized SPIONs, promoting cell migration in the desired direction.
In this study, the PEI-SPIONs were firstly used as a gene vector for ChABC to enhance its ability to eliminate CSPGs and promote the crossing of SCs through the barrier of glial scar. In addition, the MF was used to guide cell migration in a specific direction under the force of SPIONs. The purpose of this study was to establish a new strategy for enhancing the fusion of SCs with astrocytes and activate the capability of SCs to support and guide axonal regeneration after spinal cord injury (SCI).
Materials and Methods
Synthesis of the PEI-SPIONs/ChABC Complexes and PEI-SPIONs/DNA Complexes
The PEI-SPIONs (1 μg/μL) (Chemicell, Berlin, Germany) comprised ferrosoferric oxide nanoparticles with branched PEI (25 kDa) as surface modification. The complementary DNA (cDNA) encoding rat ChABC, STK39 (1638 bp, Accession number: NM_013233), was inserted into a pcDNA3.1 transfer plasmid (Genomeditech, Shanghai, China) between its unique SacII and BamHI cutting sites (ChABC plasmid). For comparison, we also synthesized a control pcDNA3.1 transfer plasmid (Genomeditech, Shanghai, China) without the target gene (DNA plasmid). In the presence of different volumes of distilled water, the PEI-SPIONs and ChABC or DNA were diluted to form different mass ratios of complexes at pH7.4 and subsequently incubated at room temperature for 30 mins to form complexes.
Characterization of PEI-SPIONs
Transmission electron microscopy (TEM) (H-600; Hitachi, Tokyo, Japan) was used to analyze the morphology, distribution, and average size of PEI-SPIONs. The zeta potential and size distribution of the PEI-SPIONs were estimated at 20–25°C using a zeta potential/nanometer particle size analyzer (DelsaNano; Beckman Coulter, Brea, CA, USA).
Culture and Purification of SCs
Primary SCs were isolated from sciatic nerves and brachial plexus of Sprague Dawley rats (postnatal days 1–3; n=100, provided by the Laboratory Animal Center of the Fourth Military Medical University[FMMU], Xi’an, China) as previously described with some modifications.29,30 All experimental procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Animal Research Committee of The Fourth Military Medical University (Xi’an, China). The epineurium was removed prior to cutting the nerve into small pieces for 2 mins, explants were dissociated with 0.2% of type II collagenase and 0.25% trypsin for 26 mins at 37°C, and mixed evenly every 5 mins. Subsequently, the cells were maintained in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12, HyClone, Logan, Utah, USA) containing 15% fetal bovine serum (FBS; Gibco, Grand Island, State of New York, USA) and 1% antibiotics (penicillin and streptomycin solution). At 24 hrs after inoculation, the cells were treated with 10 μm cytosine cytarabine (10−5M) for 48 hrs to inhibit the proliferation of fibroblasts. SCs were maintained in DMEM/F12 (HyClone) containing 15% FBS (Gibco), 1% antibiotics (penicillin and streptomycin solution) supplemented with 2 mM forskolin (Sigma-Aldrich, St. Louis, MO, USA) and 20 mg/mL bovine pituitary extract (BPE; Biomedical Technologies Inc., Stoughton, MA, USA). These cultures were highly enriched in SCs (>95%) based on the immunostaining of the SC marker S100 and p75 neurotrophin receptor (Figure 1A–D).
Culture and Purification of Astrocytes
Primary astrocytes were prepared from the cerebral cortices of Sprague Dawley rats (postnatal days 1–3; n=50, provided by the Laboratory Animal Center of the FMMU) as previously described with some modifications.30 In brief, the brain is carefully extracted under a dissecting microscope in Hank’s balanced salt solution. Subsequently, the meninges were removed and the brain was cut into small pieces, digested in 0.25% trypsin and 0.2% type IV collagenase for 30 mins at 37°C, and mixed evenly every 5 mins. The cells were plated on T75 ﬂasks coated with poly-L-lysine (PLL) and incubated in DMEM/F12 (HyClone) containing 10% FBS (Gibco) and 1% antibiotics (penicillin and streptomycin solution). The primary cultured astrocytes were shaken for 24 hrs (200 rpm) at 37°C, and microglia and oligodendrocytes were removed in the process. The astrocytes were washed twice with phosphate-buffered saline (PBS; HyClone) solution to remove any suspended cells. Finally, the medium was replaced with fresh DMEM/F12 (HyClone) containing 10% FBS and 1% antibiotics (penicillin and streptomycin solution). These cultures were highly enriched in astrocytes (>90%) based on the immunostaining of the astrocyte marker glial fibrillary acidic protein (GFAP) (Figure 1E–G).
Magnetofection of SCs
A schematic diagram of the magnetofection is shown in Figure 1H. The plasmid was diluted to a concentration of 0.08 μg/μL with distilled water. The weight ratio of the PEI-SPIONs to the ChABC plasmids was 1:4; 4 μL of PEI-SPIONs (1 μg/μL) solution was added to 200 μL of diluted plasmid solution and mixed immediately through vigorous pipetting.27 The mixture was prepared at room temperature for 30 mins by combining cDNA with magnetic nanoparticles to form PEI-SPIONs/cDNA complexes.
Primary SCs were cultured in a six-well plate with DMEM/F12 (HyClone) containing 15% FBS, 1% antibiotics (penicillin and streptomycin solution) supplemented with 2 mM forskolin (Sigma-Aldrich) and 20 mg/mL BPE (Biomedical Technologies Inc.), and cultured to 70–80% of confluency. Cells were washed twice with sterile PBS (HyClone) or DMEM/F12 (HyClone) without serum prior to transfection, and the medium was replaced with 1.8 mL fresh serum-free medium per well. Subsequently, 200 μL of the prepared PEI-SPIONs/ChABC complex or PEI-SPIONs/ChABC complex solution was added to each well of the six-well cell culture plate. After mixing, the six-well cell culture plate was placed on top of a commercial magnetic neodymium–iron–boron multi-well plate (MagnetoFACTOR-96 plate; Chemicell), the strength of which was 0.3 T, for 4 hrs of incubation at 37°C in an atmosphere containing 5% carbon dioxide. The special geometry of the MagnetoFACTOR-96 plate, the polarity of which is alternated north and south, ensures that the strength of the MF in each well is uniform and equal.
After magnetofection, the medium was replaced with fresh serum containing 15% FBS, 1% antibiotics (penicillin and streptomycin solution) supplemented with 2 mM forskolin (Sigma-Aldrich) and 20 mg/mL BPE (Biomedical Technologies Inc.), and the magnetofected SCs with PEI-SPIONs/ChABC complexes (PEI-SPIONs/ChABC/SCs) or magnetofected SCs with PEI-SPIONs/DNA complexes (PEI-SPIONs/DNA/SCs) were cultured for further use.
Cell Counting Kit 8 (CCL-8) Assays
The viability and cytotoxicity of cells were analyzed using the CCK-8 assay (Dojindo, Kumamoto, Japan) according to the instructions provided by the manufacturer. Briefly, different concentrations of PEI-SPIONs (0, 1, 2, 4, and 8 μg/mL) were magnetofected into SC in 96-well plates. After 24 or 72 hrs of incubation, the SCs were washed 3 times with sterile PBS (HyClone); subsequently, 100 μL of fresh medium containing 10 μL of CCK-8 reagent was added to each well and incubated for 4 hrs at 37°C under a humidified atmosphere with 5% carbon dioxide. The absorbance was measured at 450 nm using a microplate reader (Synergy H1, BioTek, Vermont, USA).
LIVE/DEAD assays were performed using a LIVE/DEAD Cell Imaging Kit (Thermo Fisher Scientific Inc., Wyman Street, Waltham, MA, USA) in a 24-well plate according to the instructions provided by the manufacturer. Live and dead cells became visible with green and red color. Briefly, different concentrations of PEI-SPIONs (0, 1, 2, 4, and 8 μg/mL) were magnetofected into SCs. After 24 hrs or 72 hrs of incubation, the cells were washed thrice with PBS (HyClone), followed by the addition of the staining solution. Cell viability was analyzed by counting the live and dead cells after incubation for 15 mins at 37°C. The number of viable (green) or dead (red) cells was counted using the Image Pro Plus software (Media Cybernetics, Bethesda, MI, USA).
Electron Microscopic Analysis of SCs After Magnetofection with PEI-SPIONs
Primary SCs were plated on a slide coated with PLL (Sigma-Aldrich) and magnetofected with PEI-SPIONs (2 μg/mL) to study their morphology after magnetofection. At 6 hrs after magnetofection, the cells were washed with sterile PBS (HyClone) to remove cells that had fallen off or died, followed by fixation and dehydration with serial ethanol solution. Subsequently, the cells were dried at room temperature in a vacuum atmosphere and sputter-coated with gold; and the samples were observed using a scanning electron microscope (S-3400N; Hitachi).
Primary SCs were seeded in two wells in the six-well plate and treated with PEI-SPIONs (2 μg/mL) to observe the presence of PEI-SPIONs in SCs. After 24 hrs of cultivation, the cells were handled according to the standard protocol for TEM imaging (H-600; Hitachi).
Gene Expression Analysis Through Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
Total RNA from SCs magnetofected with different safety concentrations of PEI-SPIONs (1 and 2 μg/mL) after 72 hrs was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the protocol provided by the manufacturer. Subsequently, total RNA was isolated and normalized to the number of cells. cDNA was synthesized using PrimeScript™ RT Master Mix (TaKaRa, Dalian, Liaoning Province, China), and qRT-PCR was performed using a FastStart Essential DNA Green Master (Roche, Basel, Switzerland) to measure the expression of ChABC. The sequences of primers for ChABC 5′ to 3′ were as follows: upper, AGACCCGATGGAACTGCTTG; lower, CTTTCGCCCACTGAAAACGG. The qRT-PCR parameters used were: denaturation at 95°C for 30 s; primer annealing at 59°C for 30 s; and elongation products at 72°C for 40 s. All data were calculated using the 2−∆∆Ct method. The housekeeping gene β-actin was used to normalize the levels of mRNA. The sequences of primers for β-actin 5′ to 3′ were as follows: upper, AGATCCTGACCGAGCGTGGC; lower, CCAGGGAGGAAGAGGATGCG. Assays were performed in triplicate.
Western Blotting Analysis of ChABC
Western blotting was performed as previously described.31 At 72 hrs, after removal of the media, SCs or SCs magnetofected with PEI-SPIONs/DNA or PEI-SPIONs/ChABC were seeded in six-well plates, washed twice with PBS (HyClone), and lysed using radioimmunoprecipitation assay buffer (50 mM Tris pH7.4, 150 mM sodium chloride [NaCl], 1% Triton X-100, 1% mM sodium deoxycholate, 0.1% sodium dodecyl sulfate, ethylenediaminetetraacetic acid, sodium orthovanadate, sodium fluoride, leupeptin) containing 1 mM phenylmethanesulfonyl fluoride. The lysates were collected from the plates through scraping and subjected to centrifugation at 10,000×g for 5 mins at 4°C. Total protein concentration was quantified using the bicinchoninic acid (Beyotime Institute of Biotechnology, Shanghai, China) assay. Briefly, 30 μL of total proteins was separately electrophoresed in 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis acid gel and transferred onto a polyvinylidene difluoride membrane at 0.8 mA/cm2 for 2 hrs. After blocking with a blocking solution (5% skimmed milk in Tris-buffered solution plus Tween-20: 50 mM Tris–hydrochloride, 150 mM NaCl, pH =7.5, 0.1% volume/volume Tween 20) at room temperature for 2 hrs, the membranes were incubated at 4°C overnight with mouse anti-ChABC monoclonal antibody at 1:1,000 (Novus Biologicals, CO, USA) and rabbit anti-β-tubulin monoclonal antibody at 1:3000 (Cat. 2128; CST, Boston, MA, USA). After washing twice in Tris-buffered solution plus Tween-20 for 10 mins, the membranes were incubated with a horseradish peroxidase‐conjugated secondary antibody. This was followed by washing thrice with PBS (HyClone) for 5 mins. The membranes were examined for immunoreactive proteins using ClarityTM Western ECL Substrate (BIO-RAD, CA, USA) and analyzed via the GE AI600 system (General Electric Company, Boston, MA, USA). β-tubulin was used as an internal control.
Preparation of Animals and Tissues
All animal procedures were conducted using a protocol reviewed and approved by the Institutional Ethics Committee of the FMMU. Male Sprague Dawley rats (n=6, 25–40 g, 2–3 weeks old), provided by the Laboratory Animal Center of the FMMU, were anesthetized through an intraperitoneal injection of 1% sodium pentobarbital solution (40 mg/kg) and transcardially perfused with PBS (HyClone) and 500 mL of 4% paraformaldehyde in PBS (0.1 M, pH=7.4). The spinal cord was harvested at the thoracic level and specimens were immersed in 4% paraformaldehyde for 4 hrs at 4°C. Subsequently, the cord was sequentially immersed in 25% glucose in PBS (HyClone) at 4°C until the tissue sank. Afterward, 8-μm serial sagittal sections were cut using a cryostat (CM1850; LEICA, Wetzlar, Hesse, Germany).
ChABC Activity in vitro
The dimethylmethylene blue (DMB) (Sigma-Aldrich) Assay was used to measure the level of sulfated glycosaminoglycan after degradation of chondroitin sulfate by ChABC or medium to evaluate the enzymatic activity of ChABC in SC-conditioned medium.32 For the DMB assay, 10 μL of the medium was collected daily from SCs, PEI-SPIONs/ChABC/SCs, or pure ChABC cultures incubated with 10 μL of chondroitin sulfate (0.25 mg/mL) for 2 hrs at 37°C as described previously.32,33 DMB solution 180 μL (16 mg of DMB, 2.37 g of NaCl, 3.04 g of glycine, 75 mL of 0.1 M HCl in 1 L of H2O) was mixed with 20 μL of the aforementioned reaction sample for 15 mins at 37°C and measured using a microplate reader (Synergy H1; BioTek) at 660 nm. The control group represented the absorbance of the chondroitin sulfate with the DMEM/F12 (HyClone). A linear standard curve, generated from purified ChABC, was used to evaluate the enzymatic activity of ChABC.
Cryostat sections were incubated in PBS (HyClone), in conditioned medium collected from PEI-SPIONs/ChABC/SCs cultures, or in PBS (HyClone) containing ChABC (300 mU/mL) for 3 hrs at 37°C to confirm the bioactivity of ChABC to degrade CSPGs in the spinal cord tissue.33,34 Moreover, the ability of astrocytes to express CSPGs in vitro was also demonstrated. Immunostaining of the incubated sections or astrocytes for CS-56 and GFAP was performed as described in the immunofluorescence staining subsection below.
Inverted Coverslip Migration Assays
The inverted coverslip assays were performed as previously described.35,36 The SCs, PEI-SPIONs/DNA/SCs, or PEI-SPIONs/ChABC/SCs were trypsinized with 0.125% trypsin and resuspended at a density of 2×106 cells/mL. Briefly, these three kinds of cells were plated on coverslip fragments (~5 mm2) coated with PLL. The fragments were cultured for 24–36 hrs until SCs adhered to the surface. Subsequently, the coverslips were washed thrice with sterile PBS (HyClone) to remove nonadherent cells and inverted (ie, cells facing downward) onto a glass-bottom cell culture dish coated with astrocytes at a density of 1×105 for 2 days to allow cell migration in DMEM/F12 medium containing 15% FBS, 1% antibiotic (penicillin and streptomycin solution) supplemented with 2 mM forskolin (Sigma-Aldrich) and 20 mg/mL BPE (Biomedical Technologies Inc.). An external static magnet (cube magnet; grade; cube side length: 50 mm; MF strength: 1.4 tons) was placed in parallel on the edge of the coverslip for further analysis. Subsequently, the cells were fixed and immunofluorescence staining was performed. The distance of cell migration away from the edge of the fragment was analyzed. The maximum distance of migrated SCs to the edge of the marker was measured and recorded, and the number of SCs that migrated at a distance of approximately 1800 μm was calculated. In addition, the angle θ between the long axis of each migrated SC and the outward MF direction was also measured. The orientation index, which represented orientation of SC migration, defined as Oi=cos(θ), with the angle 0, θ, π/2 (Oi=1 when the direction of SC migration overlaps with the MF direction, Oi=0.5 or 0 when the angle is 60° or 90° between the direction of SC migration and the MF direction). Values of Oi closer to 1 indicate a migration angle closer to the direction of the MF. In each experiment, more than six regions were randomly selected, and the average measured number of SCs in each region was 30. All migrations were performed under conditions of aphidicolin (1.5 μg/mL) inhibition to determine that movement away from the substance was not the result of proliferation.
SC and Astrocyte Confrontation Assays
SC and astrocyte confrontation assays were performed as previously described with some modification.35,37 Brieﬂy, 25 μL strips of astrocytes (density: 6×105/mL) or SCs (density: 2×106/mL) were plated parallel to each other on a PLL-coated confocal dish. After attachment for 3 hrs, the cells were washed with sterile PBS (HyClone). The MF was applied in parallel to the SC strips on the astrocyte side. The cells were cultured for 7 days using 15% DMEM/F12 medium containing 15% FBS, 1% antibiotic (penicillin and streptomycin solution) supplemented with 2 mM forskolin (Sigma-Aldrich) and 20 mg/mL BPE (Biomedical Technologies Inc.) and migrated toward each other. Subsequently, the cells were fixed and immunofluorescence was performed using anti-GFAP for astrocytes and anti-S100 for SCs as described in the following subsection. SCs that crossed the cell boundary and migrated to the astrocyte region were counted and more than six areas were randomly selected per condition.
Immunofluorescence staining was performed as previously described with some modification.38 The cells were fixed using 4% paraformaldehyde for 15 mins at room temperature, rinsed with PBS (HyClone) for 5 mins thrice, blocked in 0.2% Triton X-100, washed as above, and incubated with 10% normal goat serum for 1 hr. Subsequently, the cells were incubated with primary antibodies overnight at 4°C. The antibodies used were as follows: polyclonal anti-S100 protein antibody (1:100; Abcam, Cambridge, UK), polyclonal mouse anti-p75 antibody (1:100; Abcam, Cambridge, UK), polyclonal chicken anti-GFAP antibody (1:1,000; Abcam), and monoclonal mouse anti-CS56 (1:200; Sigma-Aldrich). After rewarming for 1 hr at room temperature, the cells were incubated with indocarbocyanine-conjugated goat anti-chicken (1:500; Beijing ComWin Biotech Co., Ltd., Beijing, China), indocarbocyanine-conjugated goat anti-mouse (1:200; Beijing ComWin Biotech Co., Ltd.), or fluorescein-conjugated goat anti-rabbit (1:50; Beijing ComWin Biotech Co., Ltd.) secondary antibodies for 1 hr at 37°C. After washing with thrice, the cells were stained with 4′,6-diamidino-2-phenylindole solution (Sigma-Aldrich) for 5 mins at room temperature. SCs were identified using primary anti-p75 and anti-S100 antibodies, while astrocytes were identified using anti-GFAP antibodies. The results of immunofluorescence staining were analyzed using confocal microscopy (A1+, Nikon, Tokyo, Honshu Island, Japan).
Initially, sections of spinal cord were washed in PBS (HyClone) for 5 mins and incubated in a blocking solution of 10% normal goat serum with 0.2% Triton X-100 for 1 hr at room temperature. The sections were incubated with antibodies against polyclonal chicken anti-GFAP (1:1000) or monoclonal mouse anti-CS56 (1:500) diluted in Immunol Staining Primary Antibody Dilution Buffer (Beyotime, Institute of Biotechnology) overnight. After rewarming for 1 hr at room temperature, the sections were rinsed thrice with PBS (HyClone, Utah, USA) and incubated with secondary antibodies: indocarbocyanine-conjugated goat anti-chicken (1:500; Beijing ComWin Biotech Co., Ltd.) or indocarbocyanine-conjugated goat anti-mouse (1:200; Beijing ComWin Biotech Co., Ltd.) for 1 hr at 37°C. Sections were rinsed thrice with PBS (HyClone) and covered with a square cover slide. The results of immunofluorescence staining were analyzed through confocal microscopy (A1+, Nikon).
All data in this study conformed to the positive distribution and expressed as the mean±standard deviation. Multiple comparisons of groups were conducted using one-way analysis of variance with the SPSS version 20 software package (IBM Corporation, Armonk, NY, USA). The values of Oi were expressed as their respective medians and interquartile ranges. For the DMB assay in vitro, significant differences between the groups were assessed using the parametric Student’s t-test. Differences with p < 0.05 denoted statistical significance.
Characterizations of the PEI-SPIONs and PEI-SPIONs/ChABC Complexes
TEM was used to analyze the morphological appearance of PEI-SPIONs, the average diameter of PEI-SPIONs was 27.1±2.6 nm (Figure 2A). The saturation magnetization at 3.382 Oe was 61.62 emu/g (Figure 2B). The particle size distribution and zeta potentials of the PEI-SPIONs and PEI-SPIONs/ChABC complexes were analyzed using Brownian motion video analysis laser scattering microscopy to evaluate the plasmid-binding ability of PEI-SPIONs. The average diameter and positive charge of PEI-SPIONs were 108.2±5.1 nm (Figure 2C) and 48.4±1.8 mV (Figure 2D), respectively. In contrast, the PEI-SPIONs/ChABC had an average diameter of 122.7±1.4 nm (Figure 2E) and a positive charge of 39.7±2.5 mV (Figure 2F). These data indicate that PEI-SPIONs have positive charges after binding to the plasmid, which is suitable for gene transfection into cells.
Magnetofection of SCs
In our previous study, we found that the presence of PEI-SPIONs could be detected on the cell membrane surface 2 hrs after magnetofection. The transfer of particles to the cytoplasm was initiated after 6 h; particles were detected in the cytoplasm 12–18 hrs after transfection. In the present study, particles were observed on the surface of SCs after 6 hrs of magnetofection (PEI-SPIONs, 2 μg/mL); however, there were no particles observed in the normal control SCs (Figure 3A–C). At 24 hrs after magnetofection, a cluster of PEI particles was found within the SCs (Figure 3D–F), indicating that PEI-SPIONs attached to the cells and were transferred into the cytosol at the corresponding timepoints.
Cytotoxicity Analysis of PEI-SPIONs
The CCK-8 assay was performed at 24 hrs and 72 hrs after magnetofection to evaluate the cytotoxicity of PEI-SPIONs. We performed the LIVE/DEAD assay to further investigate the cytotoxicity of PEI-SPIONs. At 24 hrs after magnetofection, the percentage of dead cells at a PEI-SPIONs of 0–4 μg/mL was 3.2–4.8%. When the concentration was increased to 8 μg/mL, the percentage of dead cells also increased to 15.83%±1.46% (Figure 4A–E and K). At 72 hrs after magnetofection, the percentage of dead cells at a PEI-SPION concentration of 0–2 μg/mL was 3.7–6.3%. When the concentration was increased to 4 μg/mL and 8 μg/mL, the percentage of dead cells also increased to 13.07%±0.97% and 17.73%±0.83%, respectively (Figure 4F–J and K). At 24 hrs, PEI-SPIONs did not have a significant effect on cell viability at concentrations of 0, 1, 2, and 4 μg/mL. However, when the concentration of PEI-SPIONs was increased to 8 μg/mL, the viability of SCs after magnectofection was significantly reduced by 38.2%. At 72 hrs, PEI-SPIONs did not show a significant effect on cell viability at concentrations of 0, 1, and 2 μg/mL. Nevertheless, when the concentration of PEI-SPIONs was increased to 4 μg/mL and 8 μg/mL, the viability of SCs was reduced by 21.3% and 44.7%, respectively (Figure 4L). These results indicate that a PEI-SPION concentration of <4 μg/mL is a safe dose. Therefore, in the remaining experiments of this study, the transfection was performed at a concentration of 2 μg/mL.
Enhanced Expression of ChABC in PEI-SPIONs/ChABC/SCs
The concentration and weight ratio of PEI-SPIONs in PEI-SPIONs/ChABC plasmids exerted effects on the expression of ChABC in PEI-SPIONs/ChABC/SCs. At safe doses of PEI-SPIONs (ie, concentration of 1 μg/mL and 2 μg/mL), the mRNA level was higher at a weight ratio of PEI-SPIONs to plasmids of 1:4 than 1:2. With the increase in the weight ratio of PEI-SPIONs/ChABC plasmids from 1:2 to 1:4, the mRNA levels of ChABC increased by 30-and 18.7-fold at 1 μg/mL and 2 μg/mL of PEI-SPIONs, respectively. Notably, the mRNA levels of PEI-SPIONs/ChABC containing 2 μg/mL PEI-SPIONs with a weight ratio of 1:4 of ChABC plasmids were 232.4-fold higher than those detected in the normal control SCs (Figure 5A). In addition, the protein levels of ChABC in normal control SCs, control PEI-SPIONs/DNA/SCs (2 μg/mL, ratio of 1:4), and PEI-SPIONs/ChABC/SCs (2 μg/mL, ratio of 1:4) were examined through Western blotting. The ChABC protein was highly expressed in PEI-SPIONs/ChABC, whereas ChABC protein was not detected in normal control SCs and PEI-SPIONs/DNA/SCs (2 μg/mL, ratio of 1:4) (Figure 5B). These results indicated enhanced expression of ChABC in ChABC-magnetofected SCs.
ChABC-Magnetofected SCs Secrete Active Chondroitinase in vitro
After incubation with conditioned medium from PEI-SPIONs/ChABC/SC (Figure 6B) cultures and purified ChABC (Figure 6C), the immunoreactivity for CS56 (to detect intact CSPGs) (green) in spinal cord sections was decreased compared with that observed in cells incubated with PBS (HyClone), especially in a dense area of astrocytes (Figure 6A). These results indicated that ChABC synthesized in PEI-SPIONs/ChABC/SCs were active. In addition, Immunofluorescence staining for CS56 and GFAP in astrocytes on the slide was performed to determine whether astrocytes could express CSPGs in vitro (Figure 6D–F). Notably, the DMB assay showed that enzymatic activity in conditioned medium from the PEI-SPIONs/ChABC/SC culture was significantly higher (2.98±0.46 mU/μL/2 hr) than that measured in control cell culture medium (0.81±0.23 mU/μL/2 hr, p < 0.001) or nontransduced SC cultures (0.82±0.45 mU/μL/2 hr, p < 0.001) (Figure 6G).
Directed and Enhanced Migration of PEI-SPIONs/ChABC/SCs on an Astrocyte Monolayer Under an Applied MF
The inverted coverslip migration assay was performed to investigate whether exogenous ChABC and PEI-SPIONs are capable of enhancing the migration of SCs over an astrocyte monolayer and manipulating the migration direction of SCs with an external MF. It was found that administration of MF or vector DNA magnetofection did not affect the migration of SCs on the astrocyte monolayer (Figure 7A–C). In contrast, the maximum migration distance of SCs was increased after magnetofection with ChABC, but not in the desired direction (Figure 7E). When SCs magnetofected with PEI-SPIONs/DNA were exposed to an MF treatment, the maximal migration distance and orientation index were significantly enhanced (Figure 7D and G–I). More interestingly, when SCs with PEI-SPIONs/ChABC (PEI-SPIONs, 2 μg/mL; PEI-SPION/ChABC, 1:4) were exposed to an MF treatment, their migration ability and orientation were further enhanced (Figure 7F and G–I), the magnetofected SCs preferentially migrated along the direction of the MF and migrated into the astrocyte monolayer. The orientation index in the PEI-SPIONs/ChABC/SCs+MF group was significantly higher than that determined in the remaining groups (Figure 7G). In addition, the maximum migration distance was greatest in the PEI-SPIONs/ChABC/SCs+MF group (1,469.47±196.00 μm), followed by the PEI-SPIONs/DNA/SCs+MF group (736.31±252.17 μm), the PEI-SPIONs/ChABC/SCs group (318.15±197.28 μm), and the remaining groups. Approximately 80–85% of the cells move in the 800 µm range. Therefore, we counted the number of cells which migrated within 800 µm. It was found that the number of SCs in the PEI-SPIONs/ChABC/SCs+MF group (61.50±7.30 cells/800 μm; Figure 7J) was significantly higher than that recorded in the PEI-SPIONs/ChABC/SCs without MF (30.83±2.79 cells/800 μm; Figure 7J). Moreover, the number of SCs at a distance of 200 µm from the edge in the PEI-SPIONs/ChABC/SCs+MF, PEI-SPIONs/DNA/SCs+MF and PEI-SPIONs/ChABC/SCs groups was 1.52-, 1.32-, and 1.17- fold than that reported in the control SC group, respectively. Similarly, the number of SCs in the PEI-SPIONs/ChABC/SCs+MF, PEI-SPIONs/DNA/SCs+MF and PEI-SPIONs/ChABC/SCs groups was 2.12-, 1.77-, and 1.23-fold higher at distances of 400 µm, and 2.70-, 2.21-, and 1.30-fold higher at distances of 600 µm than that observed in the control SC group (Figure 7J). In the PEI-SPIONs/ChABC/SCs+MF groups, the maximal distance of SC migration was 1,800 μm (Figure 7J), confirming that PEI-SPIONs/ChABC/SCs fused well with astrocytes. Collectively, these results indicate that ChABC magnetofection is capable of enhancing the migration of SCs over an astrocyte monolayer and manipulating the direction of SC migration with an external MF.
PEI-SPIONs/ChABC/SCs Crossed Boundaries When in Contact with Astrocytes and Their Direction Was Oriented by an Applied MF
The confrontation assay was performed to investigate whether PEI-SPIONs/ChABC/SCs could migrate through the astrocyte boundary and migrate into the astrocyte domain (Figure 8). A schematic diagram of the confrontation assay is shown in Figure 8G. Cell boundaries were generated between astrocytes and SCs in control SCs, nonmagnetofected SCs+MF and PEI-SPIONs/DNA/SCs (Figure 8A–C). Cells in the PEI-SPIONs/DNA/SCs+MF and PEI-SPIONs/ChABC/SCs without or with an external MF were capable of crossing the boundary formed by astrocytes (Figure 8D–F). Under the guidance of MF, SCs migrated along the direction of the MF axis in PEI-SPIONs/DNA/SCs and PEI-SPIONs/ChABC/SCs (Figure 8D and F). In addition, the number of SCs which crossed the boundary and migrated into the region of astrocytes was highest in the PEI-SPIONs/ChABC/SCs+MF group, followed by the PEI-SPIONs/DNA/SCs+MF group, the PEI-SPIONs/ChABC/SC group, and the remaining three groups (Figure 8H).
In our previous study, we have demonstrated that PEI-SPIONs/DNA/SCs could be driven by an applied MF to cross the cell boundary and migrate into the astrocyte domain. However, the maximum distance of PEI-SPIONs/DNA/SC migration is limited by their poor migration when in contact with astrocytes,14 It has been reported that a glial scar formed by astrocytes is capable of preventing SCs from passing through the boundary and migrating into the astrocyte area, which significantly limits the application of SCs in the repair of SCI.39,40 In the present study, genetically modified ChABC was introduced into SCs through magnetofection to stably express ChABC, which is capable of reducing the production of CSPGs by activated astrocytes.19 It was found that the number of cells migrating into the astrocyte region and the maximum migration distance was significantly increased in PEI-SPIONs/ChABC/SCs, especially when the cells were exposed to a stable MF. The results of this study proposed a new approach to guide and enhance the migration of PEI-SPIONs/ChABC/SCs within an astrocyte micro-environment with the aid of an applied MF. These findings highlight the application of these cells in the field of neuranagenesis in CNS.
Magnetofection offers the advantages of simplicity, high efficiency and low toxicity over other transfection methods.26,27 It has been shown that the expression efficiency of lipofectamine sharply decreased to 40.32% at 48 hrs. In contrast, the efficiency of magnetofection reached 76.6% at 72 hrs and maintained a high level (72.3%) at 120 hrs.27 Therefore, we selected magnetofection to mediate the entry of the plasmid into SCs. As a gene vector in magnetofection, SPIONs have been widely used owing to their safety profile, low toxicity, high stability, and high efficiency of transfection. Currently, SPIONs can be artificially driven by an external MF; this approach has been used in drug release, cell separation, and magnetic resonance imaging.41,42 However, studies showed that in the absence of an appropriate coating nanoparticles tend to form irreversible agglomerates.43 Therefore, it is essential to modify SPIONs with polymers to increase their stability and manipulate their surface properties to improve cell and material interface.44,45 Base on the reason above, it is important to functionalize SPIONs to achieve a positive charged surface to facilitate cell endocytosis and avoid aggregating in our study. Polyethylenimine (PEI) is a widely used cationic polymer to modify the surface of SPIONs. Furthermore, the internalized PEI-coated SPIONs (PEI-SPIONs) can exert cellular tension under an applied MF, which sufficiently initiates axonal outgrowth and cell migration in the desired direction. The PEI-SPIONs in the present study were synthetized by the company of Chemicell. Compared with SPIONs, the tendency to aggregate of PEI-SPIONs has been significantly improved. In addition, the diameter of PEI-SPIONs allows their endocytosis by the cells. In the present study, the ChABC exogenous gene was successfully expressed in cells after magnetofection with ChABC-loaded PEI-SPIONs. The surface of SPIONs is positively charged by the attachment of a polymer (eg, PEI), which is capable of adhering to cells to further increase the distribution of SPIONs on the cell membrane and internalization.46,47 In our study, the PEI-SPIONs/DNA complex adhered to the cells and was rapidly internalized under the action of an external MF after magnetofection. The presence of PEI-SPIONs has been reported on the cell surface and within the cells. The difference between the average diameter of PEI-SPIONs determined through TEM and ZetaPALS may be attributed to the agglomeration of charged PEI-SPIONs in the preparation of the sample solution for ZetaPALS.48,49 We also found that the toxicity of PEI-SPIONs is dose and time dependent. The SPIONs were less toxic to the primary SCs at concentrations <4 μg/mL. Therefore, in the present study, we selected 2 μg/mL as a safe experimental concentration.
The use of a static MF to guide the direction of cell migration has been widely investigated, especially within the vascular system.50,51 Previous studies have reported that cell migration can be enhanced by internalized magnetic nanoparticles in the presence of an MF.3,31 In the present study, we applied an external MF to SCs after internalization of SPIONs. We firstly showed that the migration ability and migration direction of SCs were not affected by the magnetofection of SPIONs in the absence of an external MF. The migration of SCs with magnetofected SPIONs was significantly enhanced after the application of a static MF. More interestingly, the SCs preferentially migrated along the axis of the MF, indicating that the MF is capable of enhancing the migration of SCs and guiding its direction with the aid of internalized SPIONs. This ability may be of great value for SCs to improve their performance in nerve injury repair.
Although the migration of SCs with internalize magnetic SPIONs was enhanced by the external MF, the glial scar formed by astrocytes remains still a strong hindrance to the migration of SCs.19 Previous studies have shown that CSPGs interact with the transmembrane receptor protein tyrosine phosphatase in axons and inhibit their growth in the injured spinal cord; this effect can be inhibited by treatment with ChABC. Numerous studies have demonstrated that both transfection of a genetically modified ChABC gene into cells or exogenous ChABC showed marked effects on the degradation of CSPGs in glial scars33 and enhanced the regeneration of transected propriospinal axons after spinal cord injury. However, local injection of ChABC is limited by the requirement for long-term infusion or repeated injections, which are associated with risks of tissue injury, immunogenicity, and infection.20,22 In this case, delivery of a vector containing the ChABC gene into glial cells may be an alternative solution. However, ChABC is a bacterial enzyme obtained from Proteus vulgaris, and its expression in mammalian cells is problematic. When the newly synthesized chondroitin peptide is secreted through eukaryotic cells, the hidden N-glycosylation sites become glycosylated, potentially interfering with the folding and secretion of ChABC. It has been shown that this process leads to failure of functional enzyme production in mammalian cells from the original bacterial chondroitinase gene. Therefore, the chondroitin enzyme gene has been modified through directional mutation of up to six selected N-glycosylation sites, which are located in important positions of structural or ligand binding. These mutations did not affect the enzyme activity in vitro. In the present study, the modified chondroitin enzyme gene was transfected into SCs, and our data showed that PEI-SPIONs/ChABC/SCs (PEI-SPIONs, 2 μg/mL; PEI-SPION/ChABC, 1:4) up-regulated the mRNA levels of ChABC by 232.4-fold versus those measured in control SCs. Furthermore, Western blotting analysis of PEI-SPIONs/ChABC/SC showed that the ChABC protein was successfully expressed. We treated the normal spinal cord with the supernatant from the PEI-SPIONs/ChABC/SCs to demonstrate the activity of the enzyme. Many studies reported that CSPGs are a class of extracellular matrix proteoglycans widely expressed within the CNS; they can be synthesized by all types of neural cells.52,53 In this study, we also found that CSPGs were expressed in the normal spinal cord tissue. In previous studies, CSPGs were highly expressed in the site of spinal cord injury.54,55 In the present study, we found that the fluorescence intensity of CS56 has been decreased after the supplementation of pure ChABC into the spinal cord section. In addition, the fluorescence intensity of CS56 of the spinal cord section was also decreased by the culture medium of PEI-SPIONs/ChABC/SCs. Collectively, the results demonstrated that ChABC protein expressed by PEI-SPIONs/ChABC/SCs is biologically active, which is capable of degrading CSPGs of spinal cord tissues. As an extracellular matrix component of the CNS, CSPGs are secreted by astrocytes. The representative confocal images of astrocyte cultures with GFAP (red) and CS56 (green) clearly demonstrated that CSPGs were located within and outside the astrocytes. The reduction of CSPGs in the area of the injured spinal cord is beneficial for promoting Schwann cell migration and nerve regeneration. Subsequently, the orientation of SC migration was effectively guided by the directional force of an external MF on internalized SPIONs. Therefore, the synergistic effects of the directional force and enhanced degradation of CSPGs by ChABC contribute to the migration of SCs into the astrocyte area.
In the present study, we firstly magnetofeced SCs using ChABC-loaded PEI-SPIONs to up-regulate the expression of ChABC, which was capable of decreasing the CSPGs secreted by astrocytes. With the directional force of an external MF on internalized SPIONs within SCs, both the number of migrated cells and the migration distance of PEI-SPIONS/ChABC/SCs were significantly increased within the astrocyte area. As the main component of a glial scar formed locally in spinal cord injury, CSPGs inhibit axonal regeneration.21 In this study, we demonstrated that ChABC from PEI-SPIONs/ChABC/SCs is bioactive and capable of degrading CSPGs in the spinal cord tissue. Moreover, the reduction of CSPGs in the area of the injured spinal cord is helpful in promoting SC migration and nerve regeneration.18 Additional studies will investigate whether PEI-SPIONs/ChABC/SCs are capable of secreting bioactive ChABC and degrading the CSPGs in an injured spinal cord animal model. Furthermore, the effect of PEI-SPIONs/ChABC/SCs on promoting nerve repair will also be evaluated in vivo in our future study. Notably, the mechanism through which the MF acts on the force of the SCs using SPIONs remains to be elucidated. More importantly, further studies are warranted to optimize the protocol for grafting magnetofected SCs into injury lesions in animal models of SCI, as well as the application of MFs to evaluate their effect on glial scar formation and axonal regeneration.
The results of the present study demonstrated that SPIONs-mediated magnetofection of ChABC is capable of up-regulating the expression of ChABC and enhancing the migration of SCs in an astrocyte-rich environment. Using an MF, the migration direction of PEI-SPIONS/ChABC/SCs was guided along the magnetic axis, leading to the fusion of magnetic SCs into astrocytes. These results raise the possibility that magnetically functionalized SCs migrate in a specific direction in astrocyte-rich injury lesions and establish an SC bridge to guide the direction of axonal regeneration to their distal destination in the CNS. This hypothesis warrants further investigation in future in vivo studies.
This work was supported by the National Basic Research Program of China (973 Program no 2014CB542206), the National Natural Science Foundation of China (Grant nos. 81672148, 81730065, 81601903 and 81802143), and Excellent Doctoral Thesis of China (Grant no. 201480). We thank Chemicell (Berlin, Germany) for kindly providing information on the magnetization of PEI-SPIONs. We also thank Lifeng Lan, Jing Liu, and Xiwang Hu, for their excellent technical assistance.
The authors report no conflicts of interest in this work.
1. Wang X, Peng C, Zhang S, et al. Polysialic-acid-based micelles promote neural regeneration in spinal cord injury therapy. Nano Lett. 2019;19(2):829–838. doi:10.1021/acs.nanolett.8b04020
2. Tran AP, Warren PM, Silver J. The biology of regeneration failure and success after spinal cord injury. Physiol Rev. 2018;98(2):881–917. doi:10.1152/physrev.00017.2017
3. Huang L, Xia B, Liu Z, Cao Q, Huang J, Luo Z. Superparamagnetic iron oxide nanoparticle-mediated forces enhance the migration of schwann cells across the astrocyte-schwann cell boundary in vitro. Front Cell Neurosci. 2017;11:83.
4. Arthur-Farraj PJ, Latouche M, Wilton DK, et al. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron. 2012;75(4):633–647. doi:10.1016/j.neuron.2012.06.021
5. Huang J, Hu X, Lu L, Ye Z, Zhang Q, Luo Z. Electrical regulation of Schwann cells using conductive polypyrrole/chitosan polymers. J Biomed Mater Res A. 2009;9999A(1):NA–NA. doi:10.1002/jbm.a.32511
6. Papastefanaki F, Chen J, Lavdas AA, Thomaidou D, Schachner M, Matsas R. Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury. Brain. 2007;130(8):2159–2174. doi:10.1093/brain/awm155
7. Houle JD, Tom VJ, Mayes D, Wagoner G, Phillips N, Silver J. Combining an autologous peripheral nervous system “bridge” and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci. 2006;26(28):7405–7415. doi:10.1523/JNEUROSCI.1166-06.2006
8. Dezawa M, Adachi-Usami E. Role of Schwann cells in retinal ganglion cell axon regeneration. Prog Retin Eye Res. 2000;19(2):171–204. doi:10.1016/S1350-9462(99)00010-5
9. Liu Z, Zhu S, Liu L, et al. A magnetically responsive nanocomposite scaffold combined with Schwann cells promotes sciatic nerve regeneration upon exposure to magnetic field. Int J Nanomedicine. 2017;12:7815–7832. doi:10.2147/IJN
10. Bunge MB. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med. 2016;31(3):262–269. doi:10.1080/10790268.2008.11760720
11. Kanno H, Pearse DD, Ozawa H, Itoi E, Bunge MB. Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus. Rev Neurosci. 2015;26(2):121–128. doi:10.1515/revneuro-2014-0068
12. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma. 2011;28(8):1611–1682. doi:10.1089/neu.2009.1177
13. Fortun J, Hill CE, Bunge MB. Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett. 2009;456(3):124–132. doi:10.1016/j.neulet.2008.08.092
14. Chaudhry N, Bachelin C, Zujovic V, et al. Myelin-associated glycoprotein inhibits schwann cell migration and induces their death. J Neurosci. 2017;37(24):5885–5899. doi:10.1523/JNEUROSCI.1822-16.2017
15. Grimpe B, Pressman Y, Bunge MB, Silver J. The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci. 2005;28(1):18–29. doi:10.1016/j.mcn.2004.06.010
16. Lakatos A, Barnett SC, Franklin RJM. Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than schwann cells following transplantation into adult CNS white matter. Exp Neurol. 2003;184(1):237–246. doi:10.1016/S0014-4886(03)00270-X
17. Wiliams RR, Bunge MB. Schwann cell transplantation: a repair strategy for spinal cord injury? Prog Brain Res. 2012;201:295–312.
18. Koh CH, Pronin S, Hughes M. Chondroitinase ABC for neurological recovery after acute brain injury: systematic review and meta-analyses of preclinical studies. Brain Injury. 2018;32(6):715–729. doi:10.1080/02699052.2018.1438665
19. Takeuchi K, Yoshioka N, Higa Onaga S, et al. Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury. Nat Commun. 2013;4(1). doi:10.1038/ncomms3740.
20. Zhao R, Muir EM, Alves JN, et al. Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons. J Neurosci Meth. 2011;201(1):228–238. doi:10.1016/j.jneumeth.2011.08.003
21. Chen M, Zheng B. Axon plasticity in the mammalian central nervous system after injury. Trends Neurosci. 2014;37(10):583–593. doi:10.1016/j.tins.2014.08.008
22. Muir EM, Fyfe I, Gardiner S, et al. Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells. J Biotechnol. 2010;145(2):103–110. doi:10.1016/j.jbiotec.2009.11.002
23. Buss A. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain. 2004;127(1):34–44. doi:10.1093/brain/awh001
24. Iwashita Y, Fawcett JW, Crang AJ, Franklin RJM, Blakemore WF. Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival. Exp Neurol. 2000;164(2):292–302. doi:10.1006/exnr.2000.7440
25. Amani H, Mostafavi E, Arzaghi H, et al. Three-dimensional graphene foams: synthesis, properties, biocompatibility, biodegradability, and applications in tissue engineering. Acs Biomater Sci Eng. 2019;5(1):193–214. doi:10.1021/acsbiomaterials.8b00658
26. Zhang X, Wu F, Men K, et al. Modified Fe3O4 magnetic nanoparticle delivery of CpG inhibits tumor growth and spontaneous pulmonary metastases to enhance immunotherapy. Nanoscale Res Lett. 2018;13(1). doi:10.1186/s11671-018-2661-8.
27. Zhao X, Cui H, Chen W, et al. Morphology, structure and function characterization of PEI modified magnetic nanoparticles gene delivery system. PLoS One. 2014;9(6):e98919. doi:10.1371/journal.pone.0098919
28. Krötz F, Wit CD, Sohn H, et al. Magnetofection—A highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther. 2003;7(5):700–710. doi:10.1016/S1525-0016(03)00065-0
29. Lopez-Verrilli MA, Picou F, Court FA. Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia. 2013;61(11):1795–1806. doi:10.1002/glia.22558
30. Afshari FT, Fawcett JW. Astrocyte-Schwann-cell coculture systems. Methods Mol Biol. 2012;814:381–391.
31. Xia B, Huang L, Zhu L, et al. Manipulation of Schwann cell migration across the astrocyte boundary by polysialyltransferase-loaded superparamagnetic nanoparticles under magnetic field. Int J Nanomed. 2016;11:6727–6741. doi:10.2147/IJN.S122358
32. Liu T, Xu J, Chan BP, Chew SY. Sustained release of neurotrophin-3 and chondroitinase ABC from electrospun collagen nanofiber scaffold for spinal cord injury repair. J Biomed Mater Res A. 2012;100A(1):236–242. doi:10.1002/jbm.a.v100a.1
33. Kanno H, Pressman Y, Moody A, et al. Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci. 2014;34(5):1838–1855. doi:10.1523/JNEUROSCI.2661-13.2014
34. Moon LDF, Asher RA, Rhodes KE, Fawcett JW. Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neuroscience. 2002;109(1):101–117. doi:10.1016/S0306-4522(01)00457-2
35. Afshari FT, Kwok JC, Fawcett JW. Analysis of Schwann-astrocyte interactions using in vitro assays. J Visualized Exp. 2011;(47):2214.
36. Cao L, Zhu YL, Su Z, et al. Olfactory ensheathing cells promote migration of Schwann cells by secreted nerve growth factor. Glia. 2007;55(9):897–904. doi:10.1002/glia.20511
37. O’Neill P, Lindsay SL, Pantiru A, et al. Sulfatase-mediated manipulation of the astrocyte-Schwann cell interface. Glia. 2017;65(1):19–33. doi:10.1002/glia.23047
38. Ma T, Wang Y, Qi F, et al. The effect of synthetic oxygen carrier-enriched fibrin hydrogel on Schwann cells under hypoxia condition in vitro. Biomaterials. 2013;34(38):10016–10027. doi:10.1016/j.biomaterials.2013.09.047
39. Okada S, Hara M, Kobayakawa K, Matsumoto Y, Nakashima Y. Astrocyte reactivity and astrogliosis after spinal cord injury. Neurosci Res. 2018;126:39–43. doi:10.1016/j.neures.2017.10.004
40. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004;5(2):146–156. doi:10.1038/nrn1326
41. Prabha G, Raj V. Preparation and characterization of chitosan-Polyethylene glycol-polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study. J Biomed Mat Res Part B. 2016;104(4):808–816. doi:10.1002/jbm.b.v104.4
42. Cicha I, Scheffler L, Ebenau A, Lyer S, Alexiou C, Goppelt-Struebe M. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: uptake and toxicity in primary human tubular epithelial cells. Nanotoxicology. 2015;10(5):557–566. doi:10.3109/17435390.2015.1095364
43. Bilyy R, Unterweger H, Weigel B, et al. Inert coats of magnetic nanoparticles prevent formation of occlusive intravascular co-aggregates with neutrophil extracellular traps. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.02266.
44. Amani H, Kazerooni H, Hassanpoor H, Akbarzadeh A, Pazoki-Toroudi H. Tailoring synthetic polymeric biomaterials towards nerve tissue engineering: a review. Artif Cells Nanomed Biotechnol. 2019;47(1):3524–3539. doi:10.1080/21691401.2019.1639723
45. Amani H, Arzaghi H, Bayandori M, et al. controlling cell behavior through the design of biomaterial surfaces: a focus on surface modification techniques. Adv Mater Interfaces. 2019;6(13):1900572. doi:10.1002/admi.v6.13
46. Mykhaylyk O, Sobisch T, Almstätter I, et al. Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria. Pharm Res-Dordr. 2012;29(5):1344–1365. doi:10.1007/s11095-011-0661-9
47. Su L, Zhang B, Huang Y, Zhang H, Xu Q, Tan J. Superparamagnetic iron oxide nanoparticles modified with dimyristoylphosphatidylcholine and their distribution in the brain after injection in the rat substantia nigra. Mat Sci Eng. 2017;81:400–406. doi:10.1016/j.msec.2017.08.049
48. Lozano O, Mejia J, Tabarrant T, et al. Quantification of nanoparticles in aqueous food matrices using particle-induced X-ray emission. Anal Bioanal Chem. 2012;403(10):2835–2841. doi:10.1007/s00216-012-5895-9
49. Lozano O, Mejia J, Masereel B, Toussaint O, Lison D, Lucas S. Development of a PIXE analysis method for the determination of the biopersistence of SiC and TiC nanoparticles in rat lungs. Nanotoxicology. 2011;6(3):263–271. doi:10.3109/17435390.2011.572301
50. Wang J, Xiang B, Deng J, et al. Externally applied static magnetic field enhances cardiac retention and functional benefit of magnetically iron-labeled adipose-derived stem cells in infarcted hearts. Stem Cell Transl Med. 2016;5(10):1380–1393. doi:10.5966/sctm.2015-0220
51. Muthana M, Scott SD, Farrow N, et al. A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther. 2008;15(12):902–910. doi:10.1038/gt.2008.57
52. Pu A, Stephenson EL, Yong VW. The extracellular matrix: focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies. Glia. 2018;66(9):1809–1825. doi:10.1002/glia.v66.9
53. Zou JL, Sun JH, Qiu S, et al. Spatial distribution affects the role of CSPGs in nerve regeneration via the actin filament-mediated pathway. Exp Neurol. 2018;307:37–44. doi:10.1016/j.expneurol.2018.05.023
54. Raspa A, Bolla E, Cuscona C, Gelain F. Feasible stabilization of chondroitinase abc enables reduced astrogliosis in a chronic model of spinal cord injury. CNS Neurosci Ther. 2019;25(1):86–100. doi:10.1111/cns.2019.25.issue-1
55. Quraishe S, Forbes LH, Andrews MR. The extracellular environment of the CNS: influence on plasticity, sprouting, and axonal regeneration after spinal cord injury. Neural Plast. 2018;2018:2952386. doi:10.1155/2018/2952386
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]